Loading stock analysis…
Evidence Synthesis
Last synthesized: 5 Sept 2026, 03:37
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
CITICHEM Sees Mixed Signs Amid Q2 Earnings Release CITICHEM's -10.69% gross margin accelerated to a -10.69% from 81.06%, marking a 81.06% marginal operating leverage, a -94.4% decline in revenue growth year-over-year, and a -3.5714288% price change percentage.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | -10.69 % | 81.06 | ▼ |
| MARGINAL_OPERATING_LEVERAGE | 81.06 % | 10.56 | ▲ |
| REVENUE_GROWTH_YOY | -94.4 % | -80 | ▼ |
| PRICE_CHANGE_PERCENT | -3.571 % | — | - |
| DAILY_VOLUME | 8,000 shares | 3,174 | ▲ |
| CLOSE_PRICE | 13.5 INR | 14 | ▼ |